🇺🇸 FDA
Pipeline program

Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge

GadoCrohn

Approved small_molecule active

Quick answer

Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge for Perianal fistula associated with Crohn's disease is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Perianal fistula associated with Crohn's disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials